Retinal Vein Occlusion Market size worth $ 25.66 Billion, Globally, by 2028 at 10.74% CAGR: Verified Market Research®

The factors that are driving the Retinal Vein Occlusion Market are Rise in a patient suffering from lymphoma, Glaucoma, Myeloma, a Growing rate of atherosclerosis and diabetes, a rise in prevalence of eye ailments, and scientific advancements

JERSEY CITY, N.J., Jan. 27, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Retinal Vein Occlusion Market" By Type (Branch Retinal Artery Occlusion And Central Retinal Vein Occlusion), By Condition (Ischemic and Non-Ischemic), By Therapy (Laser, Anti-VEGF, Steroids, and Others), By Diagnosis (Optical Coherence Tomography, Fundoscopic Examination, And Fluorescein Angiography), and By Geography. According to Verified Market Research, the Global Retinal Vein Occlusion Market size was valued at USD 11.35 Billion in 2020 and is projected to reach USD 25.66 Billion by 2028, growing at a CAGR of 10.74% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=153031

Browse in-depth TOC on "Retinal Vein Occlusion Market"

202 - Pages
126 – Tables
37 – Figures

Global Retinal Vein Occlusion Market Overview

Retinal vein occlusion (RVO) is one of the most common vascular disorders of the retina and the most common cause of vision loss across the world. It is the most common cause of blindness from retinal vascular disease after diabetic retinopathy. There is no medication available that's specific for retinal artery occlusions. Most of the people in this condition may have permanent changes to their vision. One of the main motives of treatment is to stabilize vision by sealing off leaking blood vessels.

Unfortunately, there is no particular way to unblock retinal veins, but the doctor can treat any health problems that seem to be related to RVO. Vision may come back in some eyes that had an RVO. About one-third have some improvement, about one-third stay the same, and about one-third gradually improve, but it takes a year or more to learn the outcome. In some of the cases, the blocked vessels lead to fluid accumulation in the retina, like sponges absorbing water. And in others, some chances can cause the formation of new blood vessels.

The current treatment option of RVO is minimizing the damage, as there is no scientifically proven treatment for the improvement of vision loss in the long term. This therapy aims to prevent further visual loss and complications of macular edema, ischemia, or neovascularization. In the case of Ophthalmic disorder, retinal occlusion occurs when a blood clot blocks the vein of the eye due to the size of the veins being too narrow. The use of anti-VEGF injection completely blocks an increase in new blood vessels in the eye that causes Glaucoma. The rise in ophthalmic disease globally and the increased geriatric population with eye disease coupled with increasing awareness about eye diseases may impact the expansion of the Global Retinal Vein Occlusion Market.

Key Players

The major players in the market are Ellex Medical Lasers, Bristol-Myers Squibb, Bayer, Allergen PLC, GlaxoSmithKline PLC, IRIDEX Corporation, Regeneron Pharmaceuticals, BioMedical Technologies, Carl Zeiss AG, NIDEK Co., LTD, Topcon Corporation.

Verified Market Research has segmented the Global Retinal Vein Occlusion Market On the basis of Type, Condition, Therapy, Diagnosis, and Geography.

• Retinal Vein Occlusion Market, By Type
• Branch Retinal Artery Occlusion
• Central Retinal Vein Occlusion
• Retinal Vein Occlusion Market, By Condition
• Ischemic
• Non-Ischemic
• Retinal Vein Occlusion Market, By Therapy
• Laser
• Anti-VEGF
• Steroids
• Others
• Retinal Vein Occlusion Market, By Diagnosis
• Optical Coherence Tomography
• Fundoscopic Examination
• Fluorescein Angiography
• Retinal Vein Occlusion Market by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Optometry Equipment Market By Product Type (General Examination Products, Retina and Glaucoma Examination Products), By Application (Hospital, Clinic), By Geography, Forecast, 2021-2028

Pneumatic Compression Therapy Market By Product (Compression Garments, Compression Pumps), By Application (Varicose Vein Treatment, Deep Vein Thrombosis Treatment), By Technique (Static Compression Therapy, Dynamic Compression Therapy), By Geography, Forecast, 2021-2028

Deep Vein Thrombosis Market By Treatment (Clot Busters, Blood Thinners, Inferior Vena Cava Filters and Compression Stockings), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and E-commerce), By Geography, Forecast, 2021-2028

Vein Finders Market By Type (Active Vein Finders, Passive Vein Finders), By Application (Blood draw/Venipuncture, IV Access), By End-User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Blood Donation Centers), By Geography, Forecast, 2021-2028

Best Eyewear Brands complementing wearers' faces: Spectacular accessory for millennials

Visualize Retinal Vein Occlusion Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo:  https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg